source
- Experts discuss hurdles and prospects for the first approved Fragile X therapyIn a recent episode of BioSpace's "Denatured" podcast, Hilary Rosselot of the National Fragile X Foundation and Jordi Fàbrega, co‑founder and CEO of CONNECTA Therapeutics, talked about the current…
- Biopharma hiring gaps: experts cite four key mismatches between companies and candidatesRecruiting specialists highlighted persistent disconnects between biopharma employers and job seekers, noting that misaligned expectations can slow hiring and discourage talent. One major issue st…